Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines

Blood

Volumn 88, Issue 7, 1996, Pages 2671-2682

  Rosenauer, Angelika ^b   Raelson, John V ^b   Nervi, Clara ^b   Eydoux, Patrice ^b   DeBlasio, Anthony ^b   Miller Jr , Wilson H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; DNA BINDING; DRUG RESISTANCE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0029793469     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2671.bloodjournal8872671     Document Type: Article

References (50)

1. The Retinoids: Biology, Chemistry, and Medicine (ed 2). New York, NY, Raven, 1994
2. Warrell RP Jr, de Thé H, Wang Z-Y, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
3. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Pellicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
4. Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
5. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Irti LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilore J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
6. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82:3241, 1993
7. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
8. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 78:1413, 1991
9. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr: Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299, 1992
10. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C: Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 52:3329, 1992
11. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949, 1993
12. Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, Chomienne C: Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 83:3264, 1994
13. Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, Warrell RP Jr: 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021, 1995
14. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein Inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
15. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
16. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:1, 1994
17. Mu Z-M, Chin K-V, Liu J-H, Lozano G, Chang K-S: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
18. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Bergen, R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
19. Duprez E, Ruchaud S, Houge G, Martin-Thourvenin V, Valensi F, Kastner PH, Berger R, Lanotte M: A retinoid Acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological and molecular features. Leukemia 6:1281, 1992
20. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marcheis E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein. Blood 82:1573, 1993
21. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359, 1992
22. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397, 1992
23. Chirgwin JM, Przybyla AF, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. J Biochem 18:5294, 1979
24. Miller WH Jr, Moy D, Li A, Grippo JF, Dmitrovsky E: Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene 5:511, 1990
25. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444, 1987
26. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: A nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224, 1990
27. Labbaye C, Zhang J, Lanotte M, Miller WH Jr, Cayre YE: Regulation of myeloblastin mRNA expression in myeloid leukemia cells treated with all-trans retinoic acid. Blood 81:475, 1993
28. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, De-Blasio A, Levine K, Evans RM, Dmitrovsky E: Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor-α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A 89:2694, 1992
29. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM: Identification and characterization of nuclear receptor acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci U S A 86:5854, 1989
30. Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM: Characterization of the PML-RARα chimeric product of the acute promyelocytic leukemia specific t(15;17) translocation. Cancer Res 52:3687, 1992
31. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
32. Neuman JR, Morency CA, Russian KO: A novel rapid assay for chloramphenicol acetyl transferase gene expression. Biotechniques 5:444, 1987
33. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
34. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube MP, Chambon P, Pelicci PG: Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemia. EMBO J 11:1397, 1992
35. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
36. Jetten AM, Grippo JF, Nervi C: Isolation and binding characteristics of nuclear retinoic acid receptors. Methods Enzymol 189:248, 1990
37. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347:558, 1990
38. Chiocca EA, Davies PJA, Stein JP: Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation. J Cell Biochem 39:293, 1989
39. Davies PJA, Murtaugh MP, Moore WT, Johnson GS, Lucas D: Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60). J Biol Chem 260:5166, 1985
40. de Thé H, del Mar Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A: Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343:177, 1990
41. Mangelsdorf DJ, Umesono K, Evans RM: The retinoid receptors, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine. New York, NY, Raven, 1994, p 319
42. Pratt MAC, Kralova J, McBurney MW: A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 10:6445, 1990
43. Robertson KA, Emami B, Collins SJ: Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
44. Song S, Si C-H: Retinoic acid regulation of the expression of retinoic acid receptors in wild-type and mutant embryonal carcinoma cells. FEBS LETT 256:51, 1989
45. Grignani F, Testa U, Ferrucci PF, Samoggia P, Pinto A, Gelmetti V, Fagioli M, Alcalay M, Grignani F, Nicoletti I, Peschle C, Pelicci PG: Effects of differentiation of promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein-dimerization and RARα DNA binding domains. Blood 86:262a, 1995 (abstr, suppl 1)
46. de Thé H, Lavau C, Marcio A, Chomienne C, Degos L, Dejean A: The PML-RAR-α fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
47. Kizaki M, Nakajima H, Mori S, Koiket M, Ohta M, Saito M, Koeffler HP, Iked Y: Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 83:3289, 1994
48. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pellici PG, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87:1939, 1996
49. Mader S, Leroy P, Chen J-Y, Chambon P: Multiple parameters control the selectivity of nuclear receptor for their response elements. J Biol Chem 268:591, 1993
50. Delva L, Cornic M, Balitrand N, Guidez F, Midea J-M, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175, 1993